The Filing Desk

NeuroPace vs Sanara MedTech

NeuroPace NPCE · Sanara MedTech SMTI · Health Care Equipment

Sanara MedTech reported revenue of $103 million in fiscal 2025, about the same as NeuroPace's $100 million in fiscal 2025. NeuroPace's revenue grew 25.1% in its latest year, and Sanara MedTech's grew 19.0%. NeuroPace had an operating margin of -16.3%, against 7.1% at Sanara MedTech. Free cash flow was −$11 million at NeuroPace and $2 million at Sanara MedTech.

Side by side

NeuroPaceSanara MedTech
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$100M$103M
Revenue growth25.1%19.0%
Revenue growth a year, last 5 years19.5%45.9%
Gross margin77.2%92.7%
Operating margin−16.3%7.1%
Net margin−21.5%−36.4%
Free cash flow−$11M$2M
Free cash flow margin−11.3%2.1%
Return on capital−81.8%13.0%
Net debt to EBITDA—2.6x
Dividends and buybacks$50M$0M
Change in diluted share count12.3%1.6%
Last close$8.14$32.67
P/E at the last close——
Insider trades, last 12 monthsbought $302,102, sold $399,250—
Piotroski F-score5 of 93 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
NeuroPaceSanara MedTech
Operating margin
Percent of revenue
NeuroPaceSanara MedTech
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
NeuroPaceSanara MedTech

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the NeuroPace and Sanara MedTech pages.